Brought to you by 
Syneron buys Candela in a $65mm stock swap
23 Jun 2017
Executive Summary
Syneron Medical has agreed to acquire fellow medical aesthetic device company Candela in a stock swap valued at $65mm. Shareholders get 0.29 of a Syneron common share (worth about $2.84, a 69% premium) for each Candela share.
Deal Industry
- Medical Devices
-
Medical Devices
- Laser
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Syneron buys Candela in a $65mm stock swap
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice